Find News

Filter articles

Showing 2661 to 2670 of 2890 results

Generics circle as Virginia court invalidates Celebrex patent

US13-03-2014Legal developments

The US District Court for the Eastern District of Virginia has invalidated one of Pfizer’s patents covering blockbuster arthritis drug Celebrex.

Myriad suffers setback in attempt to block Ambry BRCA test

US12-03-2014Legal developments

Genetic diagnostic company Myriad Genetics and other patent holders have been denied a motion for a preliminary injunction that would have kept rival company Ambry Genetics from selling its own test for BRCA gene mutations.

Novo Nordisk signs insulin deal with Caisson


Texas-based biopharmaceutical company Caisson Biotech has expanded its partnership with diabetes therapy maker Novo Nordisk by giving Novo exclusive rights to commercialise an insulin treatment that uses Caisson’s drug delivery technology.

Update to UPC rules clarifies “opt-out” scheme


The Unified Patent Court has clarified its opt-out scheme, making clear that when a European patent has been opted out of the scheme, its associated supplementary protection certificate will follow.

Life Sciences Law Forum: UPC: “So much more to be done”


While the political will exists for the introduction of the Unified Patent Court next year, much more still needs to be done, according to Adam Cooke, a partner in DLA Piper's IP and technology group.

Life Sciences Law Forum: disclosure of clinical data a key concern


A key concern for lawyers and in-house counsels practising in the pharmaceutical industry is the disclosure of clinical data, according to the co-chairs of DLA Piper's Global Life Sciences sector, Bonella Ramsay and John Dougherty.

Indian court dismisses Teva’s bid to block Copaxone generic


The Delhi High Court has dismissed Teva’s action to stop Hyderabad-based Natco Pharma from marketing a generic version of its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate).

Federal Circuit rejects challenge to GSK’s Avodart and Jalyn

US28-02-2014Legal developments

The US Appeals Court for the Federal Circuit has affirmed a lower court decision that GlaxoSmithKline’s patent covering Avodart and Jalyn is valid, rejecting claims put forward by a group of generic drug makers.

Bayer to buy traditional Chinese medicine group

China, Germany27-02-2014

Bayer has announced that it plans to acquire Dihon Pharmaceutical Group, a Chinese company that makes over-the-counter (OTC) and herbal traditional Chinese medicine (TCM) products.

US district court invalidates Megace patent

Taiwan, US25-02-2014Legal developments

The US District Court for the District of Maryland has ruled that Taiwanese company TWi Pharmaceuticals’ generic version of Par Pharmaceuticals’ Megace ES drug does not infringe US patent 7,101,576.

Showing 2661 to 2670 of 2890 results